Shyam is a Principal in the Medicxi investment team. Prior to joining Medicxi, Shyam founded two early-stage biotechnology companies (Shyden Biotechnology and Cleavr Therapeutics) and consulted for a number of venture capital firms and their portfolio companies.
Shyam obtained a BSc in Biochemistry and a Masters in Translational Medicine from Imperial College London.
Imperial College London
London, Stevenage (UK)
Reading, Theatre, Travel
Sarah Toulouse email@example.com